Literature DB >> 24615872

Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children.

Susana Vazquez1, Celina Lozano, Ana Beatriz Perez, Yinet Castellanos, Didye Ruiz, Naifi Calzada, Maria Guadalupe Guzmán.   

Abstract

El Salvador is a Central American country that has been affected by several dengue outbreaks. This study investigated the levels of IgM, IgA, and IgE anti-dengue antibodies in serum samples from children in El Salvador, with a clinical and serological diagnosis of dengue infection during the dengue 4 outbreak in 2002-2003. Seventy one serum samples were tested by ELISA and cases were classified in three groups: 13 primary dengue fever (PDF), 21 secondary dengue fever (SDF), and 37 secondary dengue hemorrhagic fever (SDHF). Also, the specificity of anti-dengue IgM for the different serotypes was tested. No significant differences in the IgM response were found between PDF and SDF, but these were detected between PDF and SDHF (P = 0.0053) and between SDF and SDHF (P = 0.0003). The IgA and IgE values showed a statistically significant difference between primary and secondary groups. The highest positivity percentage of IgA was between 95% (SDF) and 100% (SDHF) towards day 7 of onset of fever. All secondary cases were positive for IgE antibodies. The specificity of IgM was determined for DENV-4 virus in primary and secondary DF groups. This is the first study on dengue cases in Salvadorian children related to the immune response of different immunoglobulins to the type of infection and the clinical picture. Further prospective studies are needed to define if the pattern of immunoglobulins can determine early dengue infection and/or severity.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  IgA; IgE; IgM; Salvadorian children; dengue infection

Mesh:

Substances:

Year:  2013        PMID: 24615872     DOI: 10.1002/jmv.23833

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.

Authors:  Amanda E Calvert; Kalanthe Horiuchi; Karen L Boroughs; Yee T Ong; Kimberly M Anderson; Brad J Biggerstaff; Mars Stone; Graham Simmons; Michael P Busch; Claire Y-H Huang
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

2.  Shared IgG Infection Signatures vs. Hemorrhage-Restricted IgA Clusters in Human Dengue: A Phenotype of Differential Class-Switch via TGFβ1.

Authors:  Chung-Hao Huang; Ya-Hui Chang; Chun-Yu Lin; Wen-Hung Wang; Hui-Chung Kuan; Ya-Ju Hsieh; Yu-Wei Wang; Chung-Hsiang Yang; Jhen-Yan Chiu; Shih-Feng Tsai; Yen-Hsu Chen; Hong-Hsing Liu
Journal:  Front Immunol       Date:  2017-12-04       Impact factor: 7.561

3.  Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.

Authors:  Adam D Wegman; Hengsheng Fang; Alan L Rothman; Stephen J Thomas; Timothy P Endy; Michael K McCracken; Jeffrey R Currier; Heather Friberg; Gregory D Gromowski; Adam T Waickman
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

4.  Dengue Specific Immunoglobulin A Antibody is Present in Urine and Associated with Disease Severity.

Authors:  Hui Zhao; Shuang Qiu; Wen-Xin Hong; Ke-Yu Song; Jian Wang; Hui-Qin Yang; Yong-Qiang Deng; Shun-Ya Zhu; Fu-Chun Zhang; Cheng-Feng Qin
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

Review 5.  The Cellular Bases of Antibody Responses during Dengue Virus Infection.

Authors:  Juan Carlos Yam-Puc; Leticia Cedillo-Barrón; Elsa Maribel Aguilar-Medina; Rosalío Ramos-Payán; Alejandro Escobar-Gutiérrez; Leopoldo Flores-Romo
Journal:  Front Immunol       Date:  2016-06-06       Impact factor: 7.561

6.  Acute Zika Virus Infection in an Endemic Area Shows Modest Proinflammatory Systemic Immunoactivation and Cytokine-Symptom Associations.

Authors:  Jéssica Barletto de Sousa Barros; Paulo Alex Neves da Silva; Rosemary de Carvalho Rocha Koga; Patrícia Gonzalez-Dias; José Rodrigues Carmo Filho; Patrícia Resende Alo Nagib; Verônica Coelho; Helder I Nakaya; Simone Gonçalves Fonseca; Irmtraut Araci Hoffmann Pfrimer
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.